Susquehanna International Group
ONC

Susquehanna International Group’s BeOne Medicines Ltd ONC Stock Holding History

Susquehanna International Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.5M Buy
62,400
+11,900
+24% +$3.85M ﹤0.01% 2328
2025
Q4 		$15.3M Sell
50,500
-24,300
-32% -$7.95M ﹤0.01% 2505
2025
Q3 		$25.5M Buy
74,800
+62,600
+513% +$19M ﹤0.01% 1952
2025
Q2 		$2.95M Sell
12,200
-9,000
-42% -$2.21M ﹤0.01% 4989
2025
Q1 		$5.77M Sell
21,200
-32,000
-60% -$7.48M ﹤0.01% 3378
2024
Q4 		$9.83M Buy
53,200
+6,800
+15% +$1.39M ﹤0.01% 2689
2024
Q3 		$10.4M Sell
46,400
-27,800
-37% -$5M ﹤0.01% 2558
2024
Q2 		$10.6M Buy
74,200
+4,500
+6% +$694K ﹤0.01% 2414
2024
Q1 		$10.9M Buy
69,700
+32,700
+88% +$5.27M ﹤0.01% 2490
2023
Q4 		$6.67M Buy
37,000
+17,700
+92% +$3.2M ﹤0.01% 3243
2023
Q3 		$3.47M Sell
19,300
-25,100
-57% -$4.97M ﹤0.01% 4133
2023
Q2 		$7.92M Buy
44,400
+800
+2% +$184K ﹤0.01% 2826
2023
Q1 		$9.4M Buy
43,600
+4,600
+12% +$1.1M ﹤0.01% 2543
2022
Q4 		$8.58M Buy
39,000
+28,000
+255% +$5.14M ﹤0.01% 2476
2022
Q3 		$1.48M Buy
11,000
+1,900
+21% +$326K ﹤0.01% 5627
2022
Q2 		$1.47M Sell
9,100
-2,100
-19% -$328K ﹤0.01% 5577
2022
Q1 		$2.11M Sell
11,200
-14,200
-56% -$3.02M ﹤0.01% 5359
2021
Q4 		$6.88M Buy
25,400
+5,300
+26% +$1.79M ﹤0.01% 3224
2021
Q3 		$7.3M Buy
20,100
+16,400
+443% +$5.36M ﹤0.01% 3336
2021
Q2 		$1.27M Buy
3,700
+100
+3% +$33.1K ﹤0.01% 7090
2021
Q1 		$1.25M Sell
3,600
-7,300
-67% -$2.42M ﹤0.01% 7126
2020
Q4 		$2.82M Buy
10,900
+8,500
+354% +$2.34M ﹤0.01% 4409
2020
Q3 		$687K Sell
2,400
-5,900
-71% -$1.39M ﹤0.01% 6998
2020
Q2 		$1.56M Sell
8,300
-59,600
-88% -$9.7M ﹤0.01% 4941
2020
Q1 		$8.36M Buy
67,900
+2,200
+3% +$344K ﹤0.01% 1947
2019
Q4 		$10.9M Sell
65,700
-12,600
-16% -$2.09M ﹤0.01% 2002
2019
Q3 		$9.59M Buy
78,300
+46,000
+142% +$6.11M ﹤0.01% 2021
2019
Q2 		$4M Sell
32,300
-10,300
-24% -$1.31M ﹤0.01% 3027
2019
Q1 		$5.62M Sell
42,600
-2,600
-6% -$351K ﹤0.01% 2326
2018
Q4 		$6.34M Sell
45,200
-37,900
-46% -$5.03M ﹤0.01% 2036
2018
Q3 		$14.3M Sell
83,100
-10,600
-11% -$1.78M ﹤0.01% 1604
2018
Q2 		$14.4M Buy
93,700
+44,300
+90% +$7.9M ﹤0.01% 1595
2018
Q1 		$8.3M Sell
49,400
-20,700
-30% -$2.8M ﹤0.01% 1979
2017
Q4 		$6.85M Buy
70,100
+56,900
+431% +$5.21M ﹤0.01% 2182
2017
Q3 		$1.37M Buy
+13,200
New +$984K ﹤0.01% 4660

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Susquehanna International Group's ONC Position: Q1 2026 in Review

Susquehanna International Group increased its BeOne Medicines Ltd (ONC) stake by 321% in Q1 2026, buying an estimated $3.65M and bringing the position to 14,808 shares worth $4.4M. The position accounts for ﹤0.01% of the portfolio, ranked #4471.

Susquehanna International Group first reported a position in ONC in Q3 2016 and has held it in 24 quarters since. The position peaked at $6.07M in Q1 2020. 282 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Susquehanna International Group held 14,808 shares of BeOne Medicines Ltd worth $4.4M as of Q1 2026.
  • Susquehanna International Group bought 11,291 BeOne Medicines Ltd shares in Q1 2026, an estimated $3.65M.
  • BeOne Medicines Ltd made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4471 holding.
  • Susquehanna International Group first reported a position in BeOne Medicines Ltd in Q3 2016 and has held it in 24 quarters since.
  • Susquehanna International Group's BeOne Medicines Ltd position peaked at $6.07M in Q1 2020.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.